Search

Search Constraints

You searched for: Author/Creator Kurzeder, Christian

Search Results

1. 2022-RA-1074-ESGO AGO-OVAR 2.29 (ENGOT-ov34): atezolizumab in combination with bevacizumab and chemotherapy vs bevacizumab and chemotherapy in recurrent ovarian cancer. (20th October 2022)

2. Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34). Issue 12 (30th June 2020)

3. Comparison of patient-reported outcomes among different types of oncoplastic breast surgery procedures. Issue 9 (September 2022)

6. Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy. (August 2019)

7. ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer. (January 2017)

8. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Uterine Corpus and Cervix. (1st November 2014)

9. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine Serous Carcinoma. (1st November 2014)

10. Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer. Issue 9 (1st November 2016)